Document is current
Any future updates will be listed below
-
Authors
Gradone, Allison L.
Ma, Vincent T.
Vasbinder, Alexi
Fecher, Leslie A.
Yentz, Sarah
Hayek, Salim S.
Lao, Christopher D.
- License Information
-
More Information
Article History
Received: 7 December 2023
Accepted: 8 August 2024
First Online: 5 October 2024
Declarations
:
: VTM serves as a consulting or advisory role for Immunocore, Regeneron, Bristol Myers Squibb, Incyte, Replimune, and Partner Therapeutics. CL receives clinical trial funding from BMS, Novartis and is currently employed by BMS. LF receives clinical trial funding from BMS, Kartos, Array/Pfizer, Merck, Pfizer/EMD Serono and serves as a consultant for Elsevier. AG, AV, SY, SH have no conflicts of interest
: This study protocol (HUM00156014) is approved by the University of Michigan institutional ethical guidelines and complies with the guidelines of the responsible governmental agency. Informed consent was not obtained from the subjects as it is not applicable for this study.
: All authors consent for publication.
